Some patients find that adjusting the timing of their weekly injection may help if they perceive particular patterns of side effects, though evidence for this approach is limited
Bar-Or et al
Many of these effects are proposed to occur through CB2
Intermediates of betaine/choline metabolismincluding phosphoethanolamine, phosphocholine, and cholinealso varied with clinical improvement across domains, although not all comparisons reached statistical significance
Over time, obese patients lose roughly 12% of their body weight on Wegovy (semaglutide) and about 18% on Zepbound (tirzepatide, which targets GLP-1 and another gut hormone, GIP.) Diana Thiara, MD, medical director of the UCSF Weight Management Program, says the results can be amazing and life-changing for people with obesity, a condition linked to a host of health risks